APA (7th ed.) Citation

ASMM, V., OA, C., C, S., FM, S., B, L., B, S., . . . ME, F. d. L. (2025). Contribution to the Chemotherapy of Human Trypanosomiasis: Design, Synthesis, and Biological Evaluation of Dimeric 2‑Nitroimidazoles against Trypanosoma cruzi Amastigotes and Bloodstream Trypanosoma brucei. ACS omega, 11(1), 1546. https://doi.org/10.1021/acsomega.5c09284

Chicago Style (17th ed.) Citation

ASMM, Velez, Chaves OA, Serpa C, Salem FM, Li B, Su B, Freire-de-Lima CG, Decote-Ricardo D, and Freire de Lima ME. "Contribution to the Chemotherapy of Human Trypanosomiasis: Design, Synthesis, and Biological Evaluation of Dimeric 2‑Nitroimidazoles Against Trypanosoma Cruzi Amastigotes and Bloodstream Trypanosoma Brucei." ACS Omega 11, no. 1 (2025): 1546. https://doi.org/10.1021/acsomega.5c09284.

MLA (9th ed.) Citation

ASMM, Velez, et al. "Contribution to the Chemotherapy of Human Trypanosomiasis: Design, Synthesis, and Biological Evaluation of Dimeric 2‑Nitroimidazoles Against Trypanosoma Cruzi Amastigotes and Bloodstream Trypanosoma Brucei." ACS Omega, vol. 11, no. 1, 2025, p. 1546, https://doi.org/10.1021/acsomega.5c09284.